CI
40
-2
NWSA
62
-4
RL
76
-7
FRT
50
-3
BMY
69
-2
PG
48
-5
LEN
36
-4
HRB
33
-3
AME
62
-3
EBAY
52
5
EXPD
37
-3
CB
61
3
HON
63
3
CMI
75
-2
IVZ
69
7
ABBV
46
-4
EQT
57
-7
A
44
-3
OKE
56
-3
UNH
29
-7
CI
40
-2
NWSA
62
-4
RL
76
-7
FRT
50
-3
BMY
69
-2
PG
48
-5
LEN
36
-4
HRB
33
-3
AME
62
-3
EBAY
52
5
EXPD
37
-3
CB
61
3
HON
63
3
CMI
75
-2
IVZ
69
7
ABBV
46
-4
EQT
57
-7
A
44
-3
OKE
56
-3
UNH
29
-7
Financhill
Back

PIMCO Enhanced Short Maturity Active ESG Exch Tr Vs. Kymera Therapeutics, Inc. Industry Stock Comparison

Sell
29

EMNT
PIMCO Enhanced Short Maturity Active ESG Exch Tr

Last Price:
$98.56
Seasonality Move:
-0.2%
Buy
90

KYMR
Kymera Therapeutics, Inc.

Last Price:
$94.38
Seasonality Move:
7.7%
Sell
29
PIMCO Enhanced Short Maturity Active ESG Exch Tr (EMNT) is a Sell

Is PIMCO Enhanced Short Maturity Active ESG Exch Tr a Buy, Sell or Hold?

  • The current PIMCO Enhanced Short Maturity Active ESG Exch Tr [EMNT] share price is $98.58. The Score for EMNT is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
  • EMNT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
90
Kymera Therapeutics, Inc. (KYMR) is a Buy

Is Kymera Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Kymera Therapeutics, Inc. [KYMR] share price is $94.30. The Score for KYMR is 90, which is 80% above its historic median score of 50, and infers lower risk than normal.
  • KYMR is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.

EMNT Stock Price Chart

What is PIMCO Enhanced Short Maturity Active ESG Exch Tr's stock price today?

  • The PIMCO Enhanced Short Maturity Active ESG Exch Tr share price today is $98.58
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EMNT is experiencing selling pressure, which indicates risk of future bearish movement.

KYMR Stock Price Chart

What is Kymera Therapeutics, Inc.'s stock price today?

  • The Kymera Therapeutics, Inc. share price today is $94.30
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing slight selling pressure.

EMNT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.04 Sell
Relative Strength Index (14 RSI): 41.71 Sell
Chaikin Money Flow: -2364 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (98.55 - 98.73) Sell
Bollinger Bands (100): (98.57 - 98.79) Sell

KYMR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.92 Buy
Relative Strength Index (14 RSI): 86.88 Buy
Chaikin Money Flow: -462379 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (58.8 - 71.72) Buy
Bollinger Bands (100): (43.38 - 63.26) Buy

EMNT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 98.61 Sell
20-day SMA: 98.66 Sell
50-day SMA: 98.69 Sell
200-day SMA: 98.62 Sell
8-day EMA: 98.6 Sell
20-day EMA: 98.64 Sell
50-day EMA: 98.67 Sell
200-day EMA: 98.64 Sell

KYMR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 70 Buy
20-day SMA: 66.61 Buy
50-day SMA: 61.97 Buy
200-day SMA: 44.25 Buy
8-day EMA: 72.36 Buy
20-day EMA: 67.57 Buy
50-day EMA: 61.93 Buy
200-day EMA: 49.42 Buy

PIMCO Enhanced Short Maturity Active ESG Exch Tr Earnings Growth & EMNT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Kymera Therapeutics, Inc. Earnings Growth & KYMR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.64 per share, and a decrease next year of $0.35 per share.

PIMCO Enhanced Short Maturity Active ESG Exch Tr Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Kymera Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):